Literature DB >> 3970909

Characteristics of collagen-induced fibrinogen binding to human platelets.

C Legrand, V Dubernard, A T Nurden.   

Abstract

Polymerized type I calf skin collagen induced a time-dependent specific binding of 125I-fibrinogen to washed human platelets. Binding occurred more rapidly in a shaken rather than in an unstirred system. It was linear in the range 0.05-0.3 microM added fibrinogen and was saturated at higher fibrinogen concentrations (more than 0.8 microM). Scatchard analysis showed a single population of binding sites (16530 +/- 5410 per platelet) with a Kd = 0.53 +/- 0.23 microM. Collagen-induced 125I-fibrinogen binding to platelets was completely inhibited by ADP antagonists such as creatine phosphate/creatine phosphokinase and AMP, and partially inhibited by pretreatment of the platelets with aspirin. With both normal and aspirin-treated platelets a close correlation was observed between the amount of 125I-fibrinogen bound and the extent of dense granule secretion. Our results confirm that fibrinogen becomes bound to platelet surface receptors during collagen-induced platelet aggregation and suggest that secreted ADP is an essential cofactor in this process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970909     DOI: 10.1016/0005-2736(85)90275-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor.

Authors:  N Kieffer; A Bettaieb; C Legrand; L Coulombel; W Vainchenker; L Edelman; J Breton-Gorius
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

Authors:  T Eichholtz; K Jalink; I Fahrenfort; W H Moolenaar
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

3.  A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.

Authors:  A T Nurden; J P Rosa; D Fournier; C Legrand; D Didry; A Parquet; D Pidard
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Suppression by wortmannin of platelet responses to stimuli due to inhibition of pleckstrin phosphorylation.

Authors:  Y Yatomi; O Hazeki; S Kume; M Ui
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

5.  A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD.

Authors:  Qizhen Shi; Scot A Fahs; Jeremy G Mattson; Hongyin Yu; Crystal L Perry; Patricia A Morateck; Jocelyn A Schroeder; Jessica Rapten; Hartmut Weiler; Robert R Montgomery
Journal:  Blood Adv       Date:  2022-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.